BERLIN : The European Medicines Agency will convene a meeting on Dec. 29 to decide if there is enough data about the safety and efficacy of the COVID-19 vaccine developed by Pfizer and BioNTech for it to be approved, the regulator said Tuesday.The agency also said Tuesday it could decide as early as Jan.
12 whether to approve a rival COVID-19 vaccine developed by Moderna Inc.The German pharmaceutical company BioNTech and its US partner Pfizer said earlier Tuesday that they had asked the regulator for speeded-up, conditional approval of their coronavirus vaccine, concluding the rolling review process they initiated with the agency on Oct.